BENZODIAZEPINES CAN BE EXCLUDED FROM MEDICAID COVERAGE UNDER DRUG PRICE REBATE BILL: CONGRESS PASSES BILL OCT. 27; PMA DECRIES  UNEQUAL TREATMENT